Floatz logo

LIDOCAINE

Dyspareunia

University of CincinnatiSmall moleculePhase 3Dormant
BB
64/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
49/ 100
Competitive Position
95/ 100

Competitive context

0 Active assets in the Dyspareunia cohort.

Asset / SponsorPhaseRating
TESTOSTERONE UNDECYLATE
Creighton University
Phase 1/2CCC
Replens
Alta Bates Summit Medical Center
Early Phase 1C
COCONUT OIL
Alta Bates Summit Medical Center
Early Phase 1C

Same molecule, other indications

LIDOCAINE is also rated in:

peripheral neuropathyDormant
BBB
Indicative ·
79 / 100
View asset →
postherpetic neuralgiaDormant
BBB
Indicative ·
78 / 100
View asset →
post-operative pain, non-human animalDormant
BBB
Indicative ·
76 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →